Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 0.08 | $ 19.6M | 1 | 256.95M |
3/31/2025 | $ 0.02 | $ 4.91M | 1 | 220.27M |
12/31/2024 | $ 0.11 | $ 22.77M | 1 | 201.7M |
9/30/2024 | $ 0.19 | $ 39.13M | 1 | 208.34M |
6/30/2024 | $ 0.12 | $ 23.69M | 1 | 203.95M |
3/31/2024 | $ 0.31 | $ 56.7M | 1 | 180.34M |
12/31/2023 | $ 0.48 | $ 82.89M | 1 | 174.44M |
9/30/2023 | $ 0.76 | $ 134.92M | 1 | 177.17M |
6/30/2023 | $ 1.34 | $ 233.64M | 1 | 174.32M |
3/31/2023 | $ 1.99 | $ 335.61M | 1 | 168.53M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for SANGAMO THERAPEUTICS INC is calculated as follows: Equity [ $ 521.41M ] / (Shares WA [ 141.1M ] * Share Factor [ 1 ])
(=) BVPS [ $ 3.7 ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 4K |
---|---|
min | $ -30.1 |
max | $ 46.85 |
average | $ 10.28 |
median | $ 6.03 |
std | $ 12.44 |